How Custom Disease Models Benefit Preclinical GI and Hepatology Research With a commitment to advancing new drug development for liver and gastrointestinal (GI) diseases, Ace Therapeutics proudly announces the launch of its custom disease model development services, which come with a complete range of research services from target discovery to predictive efficacy testing. This strategic addition to Ace Therapeutics’ portfolio not only enhances its service...
0 condivisioni
120 Views
0 Anteprima